Among the companies with shares expected to actively trade in
Tuesday's session are Movado Group Inc. (MOV), Depomed Inc. (DEPO)
and Molycorp Inc. (MCP).
Movado's fiscal second quarter profit jumped a
better-than-expected 83% as the luxury watchmaker strengthened
margins and increased sales. Shares were up 13% to $34 premarket as
the company also raised its full-year outlook.
Depomed said it has licensed the rights to its Acuform gastric
retentive drug delivery technology to Johnson & Johnson (JNJ)
unit Janssen Pharmaceuticals Inc., providing the specialty
pharmaceutical company with a new and growing royalty stream.
Shares jumped 8.6% to $5.55 premarket.
Molycorp said its California facility had begun to produce heavy
rare-earth concentrate from freshly mined ore. Those rare
earths--used in such technologies as wind turbines and hybrid
electric vehicles--will then be processed in Molycorp's production
facilities. With the launch of the heavy rare earth concentrate
facilities on schedule, Chief Executive Mark Smith said Molycorp
remains on track to achieve full Phase 1 production rates at the
California site in the fourth-quarter. Shares rose 5.2% to $10.01
premarket.
Brown Shoe Co. (BWS) narrowed its fiscal second-quarter loss,
helped by lower overhead expenses. The footwear retailer also
raised the low end of its earnings target for the year. Shares were
up 5.2% to $16.20 premarket.
Cyberonics Inc.'s (CYBX) fiscal first-quarter earnings jumped
17% as the epilepsy-treatment company saw strong domestic and
international revenue, while margins also widened. Shares were up
8.4% to $49.15 premarket.
PVH Corp.'s (PVH) fiscal second-quarter earnings rose 31% as the
apparel maker posted stronger margins and lower taxes. Shares were
up 5.7% at $93.50 premarket as adjusted earnings topped
expectations.
Perfect World Co.'s (PWRD) second-quarter profit slumped 50%, as
the Chinese online-game developer was squeezed by higher expenses
and softer revenue. Shares sank 6.5% to $9.84 premarket, as the
company forecast weak current-quarter revenue.
Watchlist:
Citigroup Inc. (C) agreed to pay almost $25 million to a group
of investors who said they were misled about the quality of
mortgage-backed securities that suffered losses after the housing
market collapsed, according to a proposed settlement filed in
federal court Monday.
Denny's Corp. (DENN) has inked a deal with Musiet Group to open
10 new restaurants in Chile, the casual-dining company's first
major expansion into South America.
Forest Laboratories Inc. (FRX) said its board has adopted a
shareholder-rights plan after activist shareholder Carl Icahn
recently increased his ownership stake in the company.
General Motors Co. (GM) said it plans to temporarily halt
production of its Chevrolet Volt electric car for roughly a month
as part of a move to pare inventory.
The U.S. Food and Drug Administration Monday approved a new
Gilead Sciences Inc. (GILD) HIV medicine that combines four
ingredients into one pill.
Ralph Lauren Corp. (RL) has named Procter & Gamble Co. (PG)
executive Christopher H. Peterson as its new chief financial
officer, a month after the departure of its former financial
chief.
Sally Beauty Holdings Inc. (SBH) named its president and chief
executive, Gary G. Winterhalter, as its new chairman, replacing
James G. Berges, who retired. The company also unveiled a $300
million buyback program.
Yahoo Inc. (YHOO) named Kathy Savitt as its new chief marketing
officer, replacing Mollie Spilman, who was named to the position
only three months ago.
Write to Mia Lamar at mia.lamar@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires